2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$5.44+$0.18 (+3.52%)
Price as of Nov 11, 2026 7:55 PM EST- $205.5MMarket Cap
- -31.82%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$5.44+$0.18 (+3.52%)
TRDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.25 | ||
Change | +$0.56 (+11.94%) | ||
Open | $4.64 | ||
High | $5.29 | ||
Low | $4.64 | ||
Previous Close | $4.69 | ||
Volume | 582,145 | ||
30-Day Average Volume | 448,764 | ||
1-Week Change | 11.23% | ||
1-Month Change | -7.41% | ||
1-Year Change | -31.82% | ||
3-Year Change | -68.43% | ||
5-Year Change | -81.93% | ||
Fundamentals | |||
Shares Outstanding | 39.2M | ||
Total Assets | $266.9M | ||
Market Cap | $205.5M | ||
Enterprise Value | $93.3M | ||
Period: QTR TTM FY | |||
Revenue | $905,000.00 | ||
Net Income | -$39.7M | ||
Free Cash Flow | -$30.1M | ||
EBIT | -$39.7M | ||
EBITDA | -$39.0M | ||
Net Working Capital | $177.1M | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 103 | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | -1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue